Chr. Hansen probiotics halve risk of NEC, study
date:Dec 18, 2013
pment of the infant microbiota.

We have a strong focus on infant health and support research initiatives that will enable us to make continuous advancements, said Christian Barker, executive vice president, health nutrition division. The study findings are remarkable. From a commercial point of view, however, NEC is a small area compared to other indications such as functional bowel disorders and diarrhoea. Nonetheless, it is encouraging receiving this type of confirmation that Chr. Hansens pr
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/29 05:57